CRB3 and breast cancer: The results in this study showed that the tamoxifen‐resistant cells had more population displaying stem cell features than parental cells and that enhanced CRB3 expression in those cells reduced the stemness of the breast cancer cells, which ultimately regulates their response to tamoxifen treatment.